Metabolic therapy directed at electron transport
OwnerCharles B. Cairns, Joseph P. Ortnerinventors
Life of this patent
Estimating the term…
Abstract
A method of treating metabolic derangement is provided. Specifically, the method comprises the steps of administering an amount of an agent to alter cellular oxidative function while monitoring cellular oxidative function. The administration of the agent may be varied as a function of the monitored cellular oxidative function and will preferably be ceased when cellular oxidative function is restored.
Claims17
A method of treating metabolic derangement, characterized by cellular oxidative dysfunction, in living tissue to restore cellular oxygen utilization in the tissue, the method comprising:
- in the presence of a sufficient amount of oxygen to support cellular oxidative function, administering an amount of a cellular oxidative function altering agent other than oxygen to alter cellular oxidative function in the tissue;
- monitoring changes in cellular oxidative function produced by the administration of the agent by determining the coupling relationship between tissues oxygen availability and mitochondrial oxygen utilization;
- and
- administering an additional amount of the agent after monitoring changes in the cellular oxidative function, including varying the administration of said agent as a function of the monitored cellular oxidative function, to restore the cellular oxidative function.
A method of treating metabolic derangement, characterized by cellular oxidative dysfunction, in living tissue to restore cellular oxidative utilization in the tissue, the method comprising:
- while the living tissue is in the presence of a sufficient amount of oxygen to support cellular oxidative function, monitoring the living tissue to determine changes in the level of cellular oxidative dysfunction by determining a coupling relationship between tissue oxygen availability and the mitochondrial oxygen utilization;
- administering an amount of a cellular oxidative function altering agent other than oxygen to alter cellular oxidative function in the tissue;
- and
- repeating the steps of monitoring and administering to restore the cellular oxidative function of the tissue, including varying the administration of the agent as a function of the monitored changes in the level of cellular oxidative dysfunction.
A method of treating metabolic derangement, characterized by a decoupled relationship between tissue oxygen availability and mitochondrial oxygen utilization, in living tissue, for purposes of restoring the coupling relationship, the method comprising:
- in the presence of a sufficient amount of oxygen to support cellular oxidative function, administering an amount of a cellular oxidative function altering agent other than oxygen to alter the coupling relationship between the tissue oxygen availability and mitochondrial oxygen utilization;
- monitoring tissue oxygen availability and mitochondrial oxygen utilization;
- determining alterations in the coupling relationship between tissue oxygen availability and mitochondrial oxygen utilization produced by the administration of the agent;
- and
- administering an additional amount of the agent after monitoring alterations in the coupling relationship, including varying the administration of said agent as a function of the monitored alteration of the determined coupling relationship, to restore the coupling relationship to a desired state.
A method of treating metabolic derangement, characterized by cellular oxidative dysfunction, in living tissue to restore cellular oxygen utilization in the tissue to a desired level, the method comprising:
- administering an amount of a cellular oxidative function altering agent other than oxygen to alter cellular oxidative function in the tissue;
- measuring changes in cellular oxidative function produced by the administration of the agent by determining a coupling relationship between tissue oxygen availability and the mitochondrial oxygen utilization;
- and
- while measuring changes in cellular oxidative function, administering an amount of the agent as a function of the treatment indicator until the cellular oxidative function is restored to the desired level;
- ceasing administration of the agent when the desired level has been measured.
Dependencies are inferred from the claim text.